Monoamine Oxidase Inhibitors in Depression: History and Mythology

Bosworth D.M. , Fielding J.W. , Demarest L. , Bonaquist M. (1955) Toxicity to iproniazid (Marsilid) as it affects osseous tuberculosis Quart Bull Sea View Hosp 16: 134-140

Brodie B.B. , Pletscher A. , Shore P.A. (1956) Possible role of serotonin in brain function and in reserpine action J Pharmacol Exp Ther 116: 9

Bucci L. , Saunders J.C. (1961) A unique monoamine oxidase inhibitor for depression Am J Psychiat 118: 255-256

Crane G.E. (1956a) Further studies on iproniazid phosphate. Isonicotinil-isopropylhydrazine phosphate. Marsilid J Nerv Ment Dis 124: 322-331

Crane G.E. (1956b) The psychiatric side-effects of iproniazid Am J Psychiat 112: 494-501

Chessin M. , Dubnick B. , Kramer E.R. , Scott C.C. (1956) Modification of pharmacology of reserpine and serotonin by iproniazid Fed Proc 15: 409

Fox H.H. , Gibas J.T. (1953) Synthetic tuberculostats. VII. mono-alkyl derivatives of isonicotinylhydrazine J Org Chem 18: 994-1002

Kamman G.R. , Freeman J.G. , Lucero R.J. (1953) The effect of 1-isonicotinyl 2-isopropyl hydrazide (IIH) on the behavior of long-term mental patients J Nerv Ment Dis 118: 391-407

Kline N.S. (1958) Clinical experience with iproniazid J Clin Exp Psychopathol 19: Suppl 1 72-78

Kline N.S. (1970) Monoamine oxidase inhibitors: an unfinished picaresque tale In: Discoveries in biological psychiatry, eds F J Ayd, B Blackwell, Lippincott, Philadelphia , 194-204

Lehmann H.E. , Kline N.S. (1983) Clinical discoveries with antidepressant drugs In: Discoveries in pharmacology. Vol. 1: Psycho- and neuropharmacology, eds M J Parnham, J Bruinvels, Elsevier , Amsterdam, 209-221

Loomer H.P. , Saunders J.C. , Kline N.S. (1957) Ipromazid, an amine oxidase inhibitor, as an example of a psychic energizer Congress Rec 1382-1390

Loomer H.P. , Saunders J.C. , Kline N.S. (1958) A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer Psychiat Res Rep No. 8 Am Psychiat Assoc 129-141

Robitzek E.H. , Selikoff I.J. , Ornstein G.G. (1952) Chemotherapy of human tuberculosis with hydrazine derivatives of isonicotinic acid Quart Bull Sea View Hosp 13: 27-51

Saunders J.C. (1958) Discussion remarks J Clin Exp Psychopath 19 Suppl. 1: 84-85

Saunders J.C. (1959) Discussion remarks Ann NY Acad Sci 80: 719-725

Saunders J.C. (1963) Treatment of hospitalized depressed and schizophrenic patients with monoamine oxidase inhibitors: including reflections on pargyline Ann NY Acad Sci 107: 1081-1089

Saunders J.C. , Rochlin D.Z. , Radinger N. , Kline N.S. (1959) Iproniazid in depressed and regressed patients. In: Psychopharmacology frontiers, Little, Brown and Co , Boston, 177-194

Scherbel A.L. (1957) III. The effects of isoniazid and iproniazid in patients with rheumatoid arthritis Cleveland Clin Quart 24: 90-97

Smith J.A. (1953) The use of the isopropyl derivative of isonicotinylhydrazine (Marsilid) in the treatment of mental disease. A preliminary report Am Practitioner 4: 519-520

Zeller E.A. (1958) Enzymological effects of Marsilid and related hydrazine derivatives J Clin Exp Psychopathol 19: Suppl 1 27-32

Zeller E.A. , Barsky J. (1952) In vivo inhibition of liver and brain monoamine oxidase by 1-isonicotinyl-2-isopropyl hydrazine Proc Soc Exp Biol NY 81: 459-461

Zeller E.A. , Barsky J. , Fouts J.R. , Kirchheimer W.F. , Van Orden L.S. (1952a) Influence of isonicotinic acid hydrazide (INH) and 1-isonicotinyl-2-isopropyl hydrazide (IIH) on bacterial and mammalian enzymes Experientia 8: 349-350

Zeller E.A. , Barsky J. , Berman E.R. , Fouts J.R. (1952b) Action of isonicotinic acid hydrazide and related compounds on enzymes involved in the autonomic nervous system J Pharmacol Exp Ther 106: 427-428

Zeller E.A. , Barsky J. , Berman E.R. , Fouts J.R. (1952c) Action of isonicotinic acid hydrazide and related compounds on enzymes of brain and other tissues J Lab Clin Med 40:965-966